HBV Mutation Detail Information

> W196L Search Result


Mutation Information
Mutation Site W196L
Mutation Type Amino acid level
Gene/Protein/Region Type S
Combined Mutation rt.M204I+s.W196L;s.S207R+s.W196L
Amino acid_Mutation G741T
Genotype/Subtype D
Relevant Drug lamivudine (LAM)
Country India
Literature Information
PubMed PMID 16428891
Disease Chronic hepatitis B
Published Year 2006
Journal Intervirology
Title Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
Author Kazim SN,Sarin SK,Sharma BC,Khan LA,Hasnain SE
Evidence Following lamivudine therapy, 14 of 57 (24.5%) patients developed 16 types of S-gene mutations (sP120S, sA128V, sS143L, sW182St., sT189I, sV190A, sS193L, sI195M, sW196L, sW196St., sS207R, sI208T, sS210E, sF219S, sF220L and sC221G).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation